ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Veterinary Pharmacology and Toxicology
This article is part of the Research TopicNatural Compounds in Veterinary TherapeuticsView all 13 articles
Development and Evaluation of Clove Oil Nanoemulsion-Based Topical Cream for Anti-Inflammatory Activity in Mice
Provisionally accepted
- 1Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan
- 2Yakin Dogu Universitesi, Nicosia, Cyprus
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Inflammatory skin disorders require effective topical therapies with minimal side effects. Clove (Syzygium aromaticum) is recognized for its potent anti-inflammatory, antimicrobial, and antioxidant properties, but it has a limited clinical use due to its highly volatile nature, poor solubility, and potential skin irritation at higher concentrations. This research aimed to develop and optimize clove oil nanoemulsion (CONE)-based topical cream, characterize its physicochemical properties, and evaluate anti-inflammatory efficacy using a mouse model. CONE was prepared via ultrasonication and optimized using response surface methodology. The optimized CONE exhibited a mean droplet size of approximately 190 nm and Polydispersity Index of 0.08, with high entrapment efficiency (94.54%). GC-MS analysis confirmed eugenol as the major constituent. The nanoemulsion demonstrated strong antifungal activity. The minimum inhibitory concentration was 120µl/mL. CONE significantly enhanced antioxidant capacity compared to clove oil. The cream was formulated by incorporating CONE into carboxymethyl cellulose (CMC) matrix and evaluated for stability, pH, morphology, and drug release. The cream maintains stability, favorable organoleptic properties, and sustained drug release, particularly at a 1 mL CONE concentration. Thirty adult male albino mice (30–40g) were used and randomly divided into six groups. Hematological parameters and C-reactive protein level further supported the anti-inflammatory efficacy topical cream, with marked improvements observed in treated groups. Histopathological analysis revealed re-epithelialization and diminished inflammatory infiltration. CONE-based cream offers a promising, safe, and effective topical therapy for inflammatory skin 2 conditions. The nanoemulsion formulation enhances clove oil's bioavailability, stability, and therapeutic potential, supporting further development for clinical and cosmetic applications.
Keywords: anti-inflammatory, Nanoemulsion, Topical cream, drug release, sustainability
Received: 30 Sep 2025; Accepted: 21 Nov 2025.
Copyright: © 2025 Shafiqa, Baboo, Farooq, Majeed and Palangi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Valiollah Palangi, valiollah.palangi@neu.edu.tr
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.